<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd">
    <url>
      <loc>https://thebostonexaminer.com/article/903807262-green-energy-mechanical-launches-electrical-division-to-accelerate-greater-boston-s-clean-energy-transition</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T14:15:00+00:00</news:publication_date>
        <news:title>Green Energy Mechanical Launches Electrical Division to Accelerate Greater Boston’s Clean Energy Transition</news:title>
      </news:news>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/903608203-boston-cognitive-joins-jade-health-stakeholder-network-to-advance-dementia-care-across-europe</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T14:00:00+00:00</news:publication_date>
        <news:title>Boston Cognitive Joins JADE Health Stakeholder Network to Advance Dementia Care Across Europe</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24825897-jadehealth-boston-cognitive-log-1200x627.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904304721-cec-bank-advances-nationwide-digital-transformation-with-unified-agentic-crm</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:13:34+00:00</news:publication_date>
        <news:title>CEC Bank Advances Nationwide Digital Transformation with Unified Agentic CRM</news:title>
      </news:news>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904145473-aj-rose-carpets-flooring-expands-in-boston-area-with-new-belmont-showroom</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:12:59+00:00</news:publication_date>
        <news:title>AJ Rose Carpets &amp; Flooring Expands in Boston Area with New Belmont Showroom</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24826846-new-location-on-leonard-st-belm-1027x714.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/902996241-pure-ip-acquires-vive-communications-to-enhance-ucaas-offering-an-it-exchangenet-transaction</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Pure IP Acquires Vive Communications to Enhance UcaaS Offering, an IT ExchangeNet Transaction</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24826648-vive-communications-acquired-by-986x1439.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/903603633-askforred-com-noting-increase-in-default-notices-expands-foreclosure-education-and-equity-protection</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T09:15:00+00:00</news:publication_date>
        <news:title>AskForRed.com Noting Increase in Default Notices, Expands Foreclosure Education and Equity Protection</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24825918-a4r-updated-add-1-5-no-number-1275x1650.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904269741-creatio-partners-with-tahaluf-to-advance-agentic-no-code-transformation-in-public-and-private-sectors</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T09:13:11+00:00</news:publication_date>
        <news:title>Creatio Partners with Tahaluf to Advance Agentic, No-Code Transformation in Public and Private Sectors</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24827310-tahaluf-1200x628.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904308612-pixability-appoints-creator-economy-leader-jamie-gutfreund-to-advisory-board</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:30:00+00:00</news:publication_date>
        <news:title>Pixability Appoints Creator Economy Leader Jamie Gutfreund to Advisory Board</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2b3e957b-4c99-4de3-88e0-cd781d24b955/small/pixability-logo-red-4-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904310497-why-climate-change-is-costing-u-s-households-hundreds-of-dollars-a-year</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:13:41+00:00</news:publication_date>
        <news:title>Why climate change is costing U.S. households hundreds of dollars a year</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ZDE4ODBjNjEtMTAyOS00MGFkLTg2YTktMjJhYjQzMzM1YjdjLTEyNzMzMTEtMjAyNi0wNC0wNy1lbg==/tiny/MIT-Sloan-School-of-Management.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904308553-cangrade-research-analyzes-70-000-candidate-assessments-to-reveal-top-strengths-and-weaknesses-among-gen-z-and-millennial-workers</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>Cangrade Research Analyzes 70,000+ Candidate Assessments to Reveal Top Strengths and Weaknesses among Gen Z and Millennial Workers</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e3bc045a-7a1f-466b-a408-e3ccd5ab2417/small/cangrade-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904308956-pathai-and-medstar-health-announce-partnership-to-deploy-the-aisight-dx-digital-pathology-platform-and-advanced-ai-applications</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>PathAI and MedStar Health Announce Partnership to Deploy the AISight® Dx Digital Pathology Platform and Advanced AI Applications</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ab2bfc12-ae80-47c6-9345-a98783489ed7/small/pathai-logo-standard-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904309034-connectm-targets-50b-defense-opportunity-adds-former-pentagon-leader-brigadier-general-mark-g-beesley-to-drive-government-expansion-and-capital</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>ConnectM Targets $50B+ Defense Opportunity, Adds Former Pentagon Leader Brigadier General Mark G. Beesley to Drive Government Expansion and Capital Markets Strategy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/MTE3ZTIwNWUtMTQ1Ni00YWQ4LTk2YzQtOTBiYjQ3YWUzYmExLTEzMDQ0NDItMjAyNi0wNC0wNy1lbg==/tiny/ConnectM-Technology-Solutions-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904309128-car-buyers-are-changing-lanes-cargurus-reveals-where-consumers-are-finding-value</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>Car Buyers are Changing Lanes: CarGurus Reveals Where Consumers are Finding Value</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5e9ed825-143d-405a-9794-acd1a1ded2cc/small/cg-logo-2025-small-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904310362-gordon-brothers-releases-2026-global-asset-insights-report</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>Gordon Brothers Releases 2026 Global Asset Insights Report</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/OTI2MGU3MDEtNWJmMC00N2Y3LThhODYtNTgyM2VmN2YwOTdlLTExMTAxODYtMjAyNi0wNC0wNy1lbg==/tiny/Gordon-Brothers.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904299969-v2-communications-named-provoke-sabre-awards-finalist-for-integrated-communications-campaign-with-uipath</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>V2 Communications Named PRovoke SABRE Awards Finalist for Integrated Communications Campaign with UiPath</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/64229d21-64a2-46c6-9253-a6d791a2e107/small/v2-logo-cmyk-2x-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904299997-thrive-launches-cjis-approved-hosting-capability-for-public-safety-agencies</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>Thrive Launches CJIS-Approved Hosting Capability for Public Safety Agencies</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/fcaf797c-9107-49f6-bd64-eeb1f1ad37b1/small/thrive-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904300475-atn-international-inc-appoints-new-chief-executive-officer</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:10:37+00:00</news:publication_date>
        <news:title>ATN International, Inc. Appoints New Chief Executive Officer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/41755c2a-a394-455c-b77b-d15053512ff1/small/atn-international-logo-blue-orange-rgb-medium-1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904299599-acronis-launches-mdr-by-acronis-tru-to-provide-24-7-threat-detection-and-response-for-msps</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Acronis Launches MDR by Acronis TRU to Provide 24/7 Threat Detection and Response for MSPs</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/986ccfdd-5646-4d82-ad35-416f6228d899/medium/acronis-launches-mdr-by-acronis-tru.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904299600-ahold-delhaize-usa-introduces-pay-by-bank-partnership-with-fiserv-to-expand-digital-payment-options-for-online-grocery-orders</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Ahold Delhaize USA Introduces Pay by Bank Partnership with Fiserv to Expand Digital Payment Options for Online Grocery Orders</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a410b285-7ca5-40d5-be74-aee18ccd15de/medium/adusa-introduces-pay-by-bank-partnership-with-fiserv-to-expa.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904299835-solid-biosciences-to-participate-at-upcoming-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Solid Biosciences to Participate at Upcoming Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bb5e6b30-d9d9-464f-8c64-33a09eacc3fb/small/solid-1029x579-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904299871-akebia-therapeutics-to-conduct-investor-meetings-at-the-raymond-james-2026-biotech-innovation-symposium</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Akebia Therapeutics to Conduct Investor Meetings at the Raymond James 2026 Biotech Innovation Symposium</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c7f3708e-3328-4668-95c6-e7646efd653a/small/akebia-logo-fullcolor-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904300073-corbus-pharmaceuticals-announces-broad-alignment-with-fda-on-registration-path-for-crb-701-in-second-line-hnscc-and-cervical-cancer</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/459d6fb1-b336-4d47-8aa1-f9198bda891d/small/corbus-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904299661-akamai-technologies-to-hold-first-quarter-2026-investor-conference-call-on-thursday-may-7-at-4-30-pm-et</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>Akamai Technologies To Hold First Quarter 2026 Investor Conference Call On Thursday, May 7, at 4:30 PM ET</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4ce7685a-3da0-416d-9bc1-58cc8b7812b8/small/akamai-logo-color-rgb-bluenavy-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904300109-cervomed-to-provide-neflamapimod-clinical-program-update-and-participate-in-a-panel-on-biomarkers-at-2026-lewy-body-dementia-association-annual</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>CervoMed to Provide Neflamapimod Clinical Program Update and Participate in a Panel on Biomarkers at 2026 Lewy Body Dementia Association Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/332fd58e-5e2b-4c96-8eaf-719ac2e34f52/small/cervomed-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/903611993-netnumber-partners-with-twofive-to-bring-phone-number-intelligence-services-to-japan-and-vietnam</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T23:00:00+00:00</news:publication_date>
        <news:title>Netnumber Partners with TwoFive to bring Phone Number Intelligence Services to Japan and Vietnam</news:title>
      </news:news>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904290245-sionna-therapeutics-to-participate-in-the-raymond-james-2026-biotech-innovation-symposium</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Sionna Therapeutics to Participate in the Raymond James 2026 Biotech Innovation Symposium</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0cda8c25-e758-4f0d-86f2-875df8411a9a/small/sionna-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904290354-climb-bio-announces-fda-fast-track-designation-for-budoprutug-for-the-treatment-of-primary-membranous-nephropathy</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Climb Bio Announces FDA Fast Track Designation for Budoprutug for the Treatment of Primary Membranous Nephropathy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2a42b557-6e44-4818-bfce-2238a05f2c43/small/climb-400x400-002-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904290397-bluejay-diagnostics-inc-announces-completion-of-624-patient-enrollments-in-symon-ii-pivotal-clinical-trial</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T10:30:00+00:00</news:publication_date>
        <news:title>Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d0d4a766-5115-448d-ba8a-d522100949f1/small/bjdx-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904290061-akamai-teams-with-arrow-electronics-to-power-and-protect-digital-experiences-at-scale</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T10:28:00+00:00</news:publication_date>
        <news:title>Akamai Teams with Arrow Electronics to Power and Protect Digital Experiences at Scale</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4ce7685a-3da0-416d-9bc1-58cc8b7812b8/small/akamai-logo-color-rgb-bluenavy-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/903615104-modo-labs-named-a-leader-in-the-2026-gartner-magic-quadrant-for-workplace-experience-applications</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T16:15:00+00:00</news:publication_date>
        <news:title>Modo Labs Named a Leader in the 2026 Gartner® Magic Quadrant™ for Workplace Experience Applications</news:title>
      </news:news>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904120839-new-england-electropolishing-marks-40-years-as-america-s-premier-precision-stainless-steel-finishing-specialist</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T15:25:54+00:00</news:publication_date>
        <news:title>New England Electropolishing Marks 40 Years as America&#39;s Premier Precision Stainless Steel Finishing Specialist</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24826676-new-england-electropolishing-ow-1920x1244.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/903594276-epc-space-introduces-high-accuracy-gan-linear-regulator-evaluation-boards</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T13:00:00+00:00</news:publication_date>
        <news:title>EPC Space Introduces High-Accuracy GaN Linear Regulator Evaluation Boards</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24825859-epc7c023-and-c024-pr-graphic-1500x1201.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904100964-peo-claims-advocacy-programs-help-employees-navigate-insurance-denials-and-billing-disputes</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:42:38+00:00</news:publication_date>
        <news:title>PEO Claims Advocacy Programs Help Employees Navigate Insurance Denials and Billing Disputes</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24826529-peo-claims-advocacy-how-dedic-1200x630.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/903573110-lydonia-named-to-the-distinguished-crn-tech-elite-250-list-for-2026</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:00:00+00:00</news:publication_date>
        <news:title>Lydonia Named to the Distinguished CRN Tech Elite 250 List for 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24825785-crn-tech-elite-250-1200x627.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/903578480-imex-cargo-launches-partner-platform-connecting-primes-dbes-and-agencies</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:00:00+00:00</news:publication_date>
        <news:title>ImEx Cargo Launches Partner Platform Connecting Primes, DBEs, and Agencies</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24825810-digital-freight-infrastructure-744x400.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/903981695-meinstein-announces-launch-of-mobile-native-personal-ai-os-focused-on-on-device-intelligence</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:00:00+00:00</news:publication_date>
        <news:title>mEinstein Announces Launch of Mobile-Native Personal AI OS Focused on On-Device Intelligence</news:title>
      </news:news>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904187944-organogenesis-achieves-primary-endpoint-in-randomized-controlled-trial-of-puraply-am</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T23:02:29+00:00</news:publication_date>
        <news:title>Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPly®AM</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9c2f551f-b7b2-403a-bf43-78f1889401e5/small/organogenesis-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904173889-organogenesis-announces-successful-fda-meeting-and-plan-to-file-bla-for-renu-for-knee-osteoarthritis-pain</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T21:30:00+00:00</news:publication_date>
        <news:title>Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9c2f551f-b7b2-403a-bf43-78f1889401e5/small/organogenesis-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904161913-immuneering-to-present-at-the-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T20:05:00+00:00</news:publication_date>
        <news:title>Immuneering to Present at the 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/81d0c83f-ae53-4d6e-9c5e-d6963e02f29d/small/immuneering-logo-cropped-1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904143857-global-validation-calibration-and-standardization-in-life-sciences-market-to-reach-3-9-billion-by-2030-fueled-by-regulatory-demands-and-digital</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T18:00:00+00:00</news:publication_date>
        <news:title>Global Validation, Calibration and Standardization in Life Sciences Market to Reach $3.9 Billion by 2030, Fueled by Regulatory Demands and Digital Transformation</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904119717-celldex-therapeutics-announces-closing-of-public-offering-of-common-stock-and-full-exercise-of-underwriters-option-to-purchase-additional-shares</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T14:53:52+00:00</news:publication_date>
        <news:title>Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7a6cc287-087f-4e97-878f-7c1ed1dc5949/small/celldex-logo-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904107227-azurity-pharmaceuticals-announces-the-availability-of-arynta-lisdexamfetamine-dimesylate-oral-solution-cii</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T13:25:00+00:00</news:publication_date>
        <news:title>Azurity Pharmaceuticals Announces the Availability of ARYNTA™ (lisdexamfetamine dimesylate) Oral Solution, CII</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/MjdjZTJlZDktZTljMC00MmUyLWEwM2MtOGQ5NWI0YjczNDVmLTUwMDE1MDg3NS0yMDI2LTA0LTA2LWVu/tiny/Azurity-Pharmaceuticals.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904103434-paytronix-2026-loyalty-report-real-time-personalization-ai-powered-decisioning-drive-success</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T13:00:00+00:00</news:publication_date>
        <news:title>Paytronix 2026 Loyalty Report: Real-Time Personalization &amp; AI-Powered Decisioning Drive Success</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a0a47d40-4419-436d-b187-246e25669b64/small/access-paytronix-dark-002-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904103447-flare-therapeutics-announces-three-upcoming-poster-presentations-at-aacr-annual-meeting-2026</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T13:00:00+00:00</news:publication_date>
        <news:title>Flare Therapeutics Announces Three Upcoming Poster Presentations at AACR Annual Meeting 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/fbcb69a8-bb9a-4d13-b91e-c43f05ec2ee1/small/flaretx-logo-overlightbg-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904103518-akari-therapeutics-announces-strategic-partnership-with-wuxi-xdc-to-advance-development-of-its-novel-adc-payload-targeting-rna-splicing</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:45:00+00:00</news:publication_date>
        <news:title>Akari Therapeutics Announces Strategic Partnership with WuXi XDC to Advance Development of Its Novel ADC Payload Targeting RNA Splicing</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8d978f50-07a9-40a3-be69-45f51ccd94d9/small/akari-logo-1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904100120-nano-dimension-announces-the-sale-of-ame-and-fabrica-product-lines</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:30:00+00:00</news:publication_date>
        <news:title>Nano Dimension Announces the Sale of AME and Fabrica Product Lines</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/dd1b96fc-0b19-4125-bdcb-867c52c8f415/small/logo-nd-nw-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904096550-avalyn-appoints-jon-congleton-seasoned-biopharmaceutical-executive-to-its-board-of-directors</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:00:00+00:00</news:publication_date>
        <news:title>Avalyn Appoints Jon Congleton, Seasoned Biopharmaceutical Executive, to its Board of Directors</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/84d7bff4-ce17-433b-8c71-aa20c30f9f43/small/avalyn-logo-final-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904096655-praxis-precision-medicines-announces-positive-results-from-the-embrave-part-a-trial-of-elsunersen-in-patients-with-scn2a-early-onset-developmental-and</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:00:00+00:00</news:publication_date>
        <news:title>Praxis Precision Medicines Announces Positive Results from the EMBRAVE Part A Trial of Elsunersen in Patients with SCN2A Early-Onset Developmental and Epileptic Encephalopathy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bff1e728-30ed-46c6-81e1-8bbc795929c0/small/01-primarylogo-color-bluex-100-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904096727-anna-autism-care-appoints-ariana-boutain-phd-bcba-d-as-chief-clinical-officer</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:00:00+00:00</news:publication_date>
        <news:title>ANNA Autism Care Appoints Ariana Boutain, PhD, BCBA-D as Chief Clinical Officer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NWMwMTNkZjMtYTQwYi00YjY3LTkzNjctOWU3ZGMyZTY3Y2ZiLTEzMjA4ODAtMjAyNi0wNC0wNi1lbg==/tiny/ANNA-HEALTH-INCORPORATED.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904092950-organogenesis-holdings-inc-to-report-first-quarter-of-fiscal-year-2026-financial-results-on-may-7-2026</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T11:30:00+00:00</news:publication_date>
        <news:title>Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9c2f551f-b7b2-403a-bf43-78f1889401e5/small/organogenesis-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904089912-stipple-bio-emerges-from-stealth-with-oversubscribed-100-million-series-a-financing-to-advance-stp-100-into-early-clinical-studies-and-advance-a</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T11:00:00+00:00</news:publication_date>
        <news:title>Stipple Bio Emerges From Stealth with Oversubscribed $100 Million Series A Financing to Advance STP-100 into Early Clinical Studies and Advance a Precision Oncology Pipeline that Leverages its Pointillist Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/96c458bd-cad2-4343-89d4-8c60bcfde0a5/small/stipple-no-name-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904089932-agios-to-host-first-quarter-2026-financial-results-conference-call-and-webcast-on-april-29-at-8-00-a-m-et</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T11:00:00+00:00</news:publication_date>
        <news:title>Agios to Host First Quarter 2026 Financial Results Conference Call and Webcast on April 29 at 8:00 a.m. ET</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c7d64dad-71c8-47cc-a58d-c93a49ce8f01/small/agios-2021-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904089975-neumora-therapeutics-to-participate-in-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T11:00:00+00:00</news:publication_date>
        <news:title>Neumora Therapeutics to Participate in 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/48256578-6cd3-4332-bf9b-2f52cfa248b7/small/neumora-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/904086918-beacon-biosignals-upsizes-series-b-financing-to-over-97-million</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T10:30:00+00:00</news:publication_date>
        <news:title>Beacon Biosignals Upsizes Series B Financing to Over $97 Million</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0485bb01-d362-473e-8fae-a6cab3b804aa/small/beacon-logo-inline-1-jpg.jpg</image:loc>
        </image:image>
    </url>
</urlset>
